Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Acute Pisa syndrome after administration of a single dose of mirtazapine.

Méndez Guerrero A, Llamas S, Murcia FJ, Ruíz J.

Clin Neuropharmacol. 2013 Jul-Aug;36(4):133-4. doi: 10.1097/WNF.0b013e318297593d.

PMID:
23783006
2.

Acute reversible dyskinesia induced by mirtazapine.

Konitsiotis S, Pappa S, Mantas C, Mavreas V.

Mov Disord. 2005 Jun;20(6):771. No abstract available.

PMID:
15732128
3.

Re-administration of mirtazapine could overcome previous mirtazapine- associated restless legs syndrome?

Pae CU, Kim TS, Kim JJ, Chae JH, Lee CU, Lee SJ, Paik IH, Lee C.

Psychiatry Clin Neurosci. 2004 Dec;58(6):669-70. No abstract available.

4.

Dystonia induced by mirtazapine.

Lu R, Hurley AD, Gourley M.

J Clin Psychiatry. 2002 May;63(5):452-3. No abstract available.

PMID:
12019672
5.

Mirtazapine-induced manic switch in adolescent unipolar depression.

Goyal N, Sinha VK.

Aust N Z J Psychiatry. 2008 Dec;42(12):1070-1. No abstract available.

PMID:
19031640
6.

Lack of drug interactions between mirtazapine and risperidone in psychiatric patients: a pilot study.

Loonen AJ, Doorschot CH, Oostelbos MC, Sitsen JM.

Eur Neuropsychopharmacol. 1999 Dec;10(1):51-7.

PMID:
10647097
7.

Mirtazapine, a sedating antidepressant, and improved driving safety in patients with major depressive disorder: a prospective, randomized trial of 28 patients.

Shen J, Moller HJ, Wang X, Chung SA, Shapiro GK, Li X, Shapiro CM.

J Clin Psychiatry. 2009 Mar;70(3):370-7. Epub 2009 Jan 13.

PMID:
19192466
8.

Mirtazapine for depression in patients with human immunodeficiency virus.

Elliott AJ, Roy-Byrne PP.

J Clin Psychopharmacol. 2000 Apr;20(2):265-7. No abstract available.

PMID:
10770469
9.

Treatment-refractory depression successfully treated with the combination of mirtazapine and lithium.

Moustgaard G.

J Clin Psychopharmacol. 2000 Apr;20(2):268. No abstract available.

PMID:
10770470
10.

Mirtazapine for treatment-resistant depression: a preliminary report.

Wan DD, Kundhur D, Solomons K, Yatham LN, Lam RW.

J Psychiatry Neurosci. 2003 Jan;28(1):55-9.

11.

Mirtazapine-associated dose-dependent and asymptomatic elevation of hepatic enzymes.

Adetunji B, Basil B, Mathews M, Osinowo T.

Ann Pharmacother. 2007 Feb;41(2):359. Epub 2007 Jan 23. No abstract available.

PMID:
17244643
12.

Occurrence of mirtazapine-induced delirium in organic brain disorder.

Bailer U, Fischer P, Küfferle B, Stastny J, Kasper S.

Int Clin Psychopharmacol. 2000 Jul;15(4):239-43.

PMID:
10954066
13.

Mirtazapine: clinical advantages in the treatment of depression.

Burrows GD, Kremer CM.

J Clin Psychopharmacol. 1997 Apr;17 Suppl 1:34S-39S. Review.

PMID:
9090576
14.

Mirtazapine and hyperpigmentation.

Mendhekar D, Inamdar A.

World J Biol Psychiatry. 2009;10(4 Pt 2):688-9. doi: 10.1080/15622970902897438. No abstract available.

PMID:
19404867
15.

Hyperglycaemia secondary to mirtazapine therapy in a 37-year-old man.

Chen R, Lopes J.

Aust N Z J Psychiatry. 2008 Nov;42(11):990-1. No abstract available.

PMID:
18946939
16.

Sertraline- and mirtazapine-induced severe neutropenia.

Ozcanli T, Unsalver B, Ozdemir S, Ozmen M.

Am J Psychiatry. 2005 Jul;162(7):1386. No abstract available.

PMID:
15994730
17.

Mirtazapine induced mania in a woman with major depression in the absence of features of bipolarity.

Basavraj V, Nanjundappa GB, Chandra PS.

Aust N Z J Psychiatry. 2011 Oct;45(10):901. doi: 10.3109/00048674.2011.589369. Epub 2011 Jun 21. No abstract available.

PMID:
21692606
18.

Influence of mirtazapine on urinary free cortisol excretion in depressed patients.

Schule C, Baghai T, Rackwitz C, Laakmann G.

Psychiatry Res. 2003 Oct 15;120(3):257-64.

PMID:
14561437
19.

First report of mirtazapine overdose.

Hoes MJ, Zeijpveld JH.

Int Clin Psychopharmacol. 1996 Jun;11(2):147.

PMID:
8803652
20.

A case of pulmonary thromboembolism and rhabdomyolysis during therapy with mirtazapine and risperidone.

Zink M, Knopf U, Argiriou S, Kuwilsky A.

J Clin Psychiatry. 2006 May;67(5):835. No abstract available.

PMID:
16841636

Supplemental Content

Support Center